Neuroglee Therapeutics

📍 Boston, United States🗓 Founded 2020👥 41 employees💰 Last funded Sep 2020
Biotechnology Research🌐 neuroglee.com
Website LinkedIn
Neuroglee Therapeutics develops personalized, evidence-based virtual care solutions to treat and manage patients with neurological conditions. Neuroglee’s adaptive learning platform leverages machine learning to dynamically personalize and optimize treatment based on patients’ unique needs. By combining best-in-class cognitive rehabilitation strategies and virtual care management delivered by an experienced, interdisciplinary clinical team, Neuroglee improves patient outcomes, reduces caregiver and clinician burden, and enhances the overall patient experience. Neuroglee also offers a digital therapeutic candidate, NG-001, which may be used as a stand-alone therapy or combined with pharmacotherapy to empower people living with MCI to obtain the highest quality care for preserving cognition and promoting independence. For more information, visit neuroglee.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Neuroglee Therapeutics?
Neuroglee Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neuroglee Therapeutics last raise funding?
The most recent investment in Neuroglee Therapeutics recorded on gritt.io was in September 2020.
When was Neuroglee Therapeutics founded?
Neuroglee Therapeutics was founded in 2020.
What industry is Neuroglee Therapeutics in?
Neuroglee Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neuroglee Therapeutics based?
Neuroglee Therapeutics is headquartered in Boston, United States.